Sanofi’s subsidiary Genzyme is collaborating with gene therapy company Voyager Therapeutics for gene therapies for severe central nervous system (CNS) disorders. The companies announced today that they have entered into a major strategic collaboration to discover, develop and commercialize novel gene therapies for CNS disorders, leveraging Genzyme’s leadership in adeno-associated …